Current eye research · 2012
Aqueous humor and plasma adiponectin levels in proliferative diabetic retinopathy patients.
Сравнительное исследованиеСтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Mao Danna, Peng Hui, Li Qiuhong, Wang Jun, Li Pinghua, Hu Ke, Zhang Xuedong, Lei Bo
Аннотация
PURPOSE: To study whether aqueous humor (AH) and plasma adiponectin (APN) levels were altered in proliferative diabetic retinopathy (PDR).
MATERIALS AND METHODS: After excluding subjects with hypertension, hyperlipidaemia, nephropathy, coronary heart disease, heart and renal failure, 20 consecutive type 2 diabetes mellitus (DM) PDR patients and 20 consecutive age-matched non-diabetic and senile cataract (non-DM) controls were enrolled in this study. AH APN and plasma APN concentrations were determined by enzyme-linked immunosorbent assay (ELISA). The expression of AdipoR1/R2 mRNA in peripheral blood mononuclear cells (PBMCs) was measured by real-time polymerase-chain reaction (PCR). The correlations between two parameters, including plasma and AH APN, AdipoR1/R2, plasma insulin and plasma glucose, were analyzed by Pearson's correlation.
RESULTS: In non-DM subjects, the APN concentration in AH was 1.26 ± 0.56 ng/ml, approximately 1/2500 of that in plasma (3.15 ± 1.36 μg/ml). The averaged AH APN concentration in PDR patients was significant higher than that of the non-DM controls (5.29 ± 4.09 ng/ml vs. 1.26 ± 0.56 ng/ml, p < 0.001). Plasma total APN was not correlated with AH APN in the PDR patients, controls or all subjects. No significant difference was observed in plasma total APN levels and AdipoR1/R2 mRNA levels in PBMCs between the PDR patients and the controls (p > 0.05).
CONCLUSION: Differences in APN concentration between AH and plasma suggest blood-retinal barrier (BRB) plays a key role in maintaining intraocular APN homeostasis. The high APN level in AH may be associated with PDR.
MATERIALS AND METHODS: After excluding subjects with hypertension, hyperlipidaemia, nephropathy, coronary heart disease, heart and renal failure, 20 consecutive type 2 diabetes mellitus (DM) PDR patients and 20 consecutive age-matched non-diabetic and senile cataract (non-DM) controls were enrolled in this study. AH APN and plasma APN concentrations were determined by enzyme-linked immunosorbent assay (ELISA). The expression of AdipoR1/R2 mRNA in peripheral blood mononuclear cells (PBMCs) was measured by real-time polymerase-chain reaction (PCR). The correlations between two parameters, including plasma and AH APN, AdipoR1/R2, plasma insulin and plasma glucose, were analyzed by Pearson's correlation.
RESULTS: In non-DM subjects, the APN concentration in AH was 1.26 ± 0.56 ng/ml, approximately 1/2500 of that in plasma (3.15 ± 1.36 μg/ml). The averaged AH APN concentration in PDR patients was significant higher than that of the non-DM controls (5.29 ± 4.09 ng/ml vs. 1.26 ± 0.56 ng/ml, p < 0.001). Plasma total APN was not correlated with AH APN in the PDR patients, controls or all subjects. No significant difference was observed in plasma total APN levels and AdipoR1/R2 mRNA levels in PBMCs between the PDR patients and the controls (p > 0.05).
CONCLUSION: Differences in APN concentration between AH and plasma suggest blood-retinal barrier (BRB) plays a key role in maintaining intraocular APN homeostasis. The high APN level in AH may be associated with PDR.